Psychiatry and Neurology, Neurology · Philadelphia, PA
NPI
1881615490
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
900 Walnut St
Philadelphia, PA, 19107
Phone (215) 955-1234
Groups this clinician bills Medicare through
Medicare paid, 2024
$73K
1,034 services
Medicare patients, 2024
358
Average age 74
Drug cost, 2024
$1.6M
2,834 prescriptions
Company payments, 2025
$165
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Tsao Wei Liang was code 99214 (office e&m - established), 203 times for 138 patients. In total Tsao Wei Liang billed 1,034 services in 26 codes, and Medicare paid $73K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-02-20.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 203 | 138 | $75.23 | $15K |
| 99214 Office E&M - Established | Facility | 123 | 89 | $67.16 | $8,261 |
| 99215 Office E&M - Established | Facility | 121 | 83 | $111.48 | $13K |
| 99215 Office E&M - Established | Office | 66 | 54 | $116.09 | $7,662 |
| 95874 Musculoskeletal | Facility | 45 | 19 | $15.04 | $677 |
| 95983 Electrical Nerve Conductivity | Facility | 44 | 25 | $39.61 | $1,743 |
| 99213 Office E&M - Established | Office | 44 | 34 | $51.33 | $2,258 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 37 | 37 | $11.87 | $439 |
| 64616 Musculoskeletal | Facility | 37 | 16 | $122.11 | $4,518 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 32 | 29 | $11.76 | $376 |
| 64611 Musculoskeletal | Office | 25 | 12 | $88.60 | $2,215 |
| 95984 Electrical Nerve Conductivity | Facility | 24 | 14 | $34.66 | $832 |
| 99232 Hospital E&M - Subsequent | Facility | 15 | 11 | $63.48 | $952 |
| 99213 Office E&M - Established | Facility | 12 | 11 | $48.69 | $584 |
By year: 2022 $78K for 1,219 services; 2023 $82K for 1,156 services; 2024 $73K for 1,034 services.
Medicare prescription drug claims, 2024
In 2024, the drug Tsao Wei Liang prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 664 prescriptions and refills. In total Tsao Wei Liang wrote 2,834 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 664 | 1,779 | 206 | $34K |
| Rasagiline Mesylate Generic | 278 | 745 | 80 | $61K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 231 | 619 | 71 | $8,246 |
| Rytary Carbidopa/Levodopa | 159 | 313 | 37 | $252K |
| Donepezil Hcl Generic | 109 | 277 | 33 | $1,556 |
| Amantadine Amantadine Hcl | 106 | 237 | 29 | $4,268 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 86 | 218 | 23 | $2,216 |
| Clonazepam Generic | 83 | 93 | 18 | $763 |
| Rivastigmine Generic | 72 | 160 | 22 | $16K |
| Nuplazid Pimavanserin Tartrate | 69 | 83 | 13 | $445K |
| Sertraline Hcl Generic | 61 | 175 | 25 | $480 |
| Droxidopa Generic | 58 | 58 | Under 11 | $197K |
| Neupro Rotigotine | 49 | 117 | 18 | $97K |
| Entacapone Generic | 43 | 120 | 15 | $7,805 |
| Selegiline Hcl Generic | 41 | 112 | 14 | $5,109 |
Brand drugs: - claims; generic drugs: 2,335 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Tsao Wei Liang $165 ($165 in general payments such as food, travel and fees) from 4 companies. The largest payer was Abbott Laboratories with $135.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.